Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,945 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rapid response of brain metastasis to crizotinib in a patient with ALK rearrangement-positive non-small-cell lung cancer.
Kaneda H, Okamoto I, Nakagawa K. Kaneda H, et al. Among authors: nakagawa k. J Thorac Oncol. 2013 Apr;8(4):e32-3. doi: 10.1097/JTO.0b013e3182843771. J Thorac Oncol. 2013. PMID: 23486271 No abstract available.
Mutational analysis of the beta-tubulin gene in lung cancer.
Tsurutani J, Komiya T, Uejima H, Tada H, Syunichi N, Oka M, Kohno S, Fukuoka M, Nakagawa K. Tsurutani J, et al. Among authors: nakagawa k. Lung Cancer. 2002 Jan;35(1):11-6. doi: 10.1016/s0169-5002(01)00291-4. Lung Cancer. 2002. PMID: 11750707
Point mutations in the topoisomerase I gene in patients with non-small cell lung cancer treated with irinotecan.
Tsurutani J, Nitta T, Hirashima T, Komiya T, Uejima H, Tada H, Syunichi N, Tohda A, Fukuoka M, Nakagawa K. Tsurutani J, et al. Among authors: nakagawa k. Lung Cancer. 2002 Mar;35(3):299-304. doi: 10.1016/s0169-5002(01)00425-1. Lung Cancer. 2002. PMID: 11844605
[ZD1839].
Nakagawa K. Nakagawa K. Nihon Rinsho. 2002 May;60 Suppl 5:378-83. Nihon Rinsho. 2002. PMID: 12101693 Review. Japanese. No abstract available.
Ritterazine B, a new cytotoxic natural compound, induces apoptosis in cancer cells.
Komiya T, Fusetani N, Matsunaga S, Kubo A, Kaye FJ, Kelley MJ, Tamura K, Yoshida M, Fukuoka M, Nakagawa K. Komiya T, et al. Among authors: nakagawa k. Cancer Chemother Pharmacol. 2003 Mar;51(3):202-8. doi: 10.1007/s00280-002-0558-8. Epub 2003 Jan 14. Cancer Chemother Pharmacol. 2003. PMID: 12655437
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].
Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Macleod A, Feyereislova A, Dong RP, Baselga J. Fukuoka M, et al. Among authors: nakagawa k. J Clin Oncol. 2003 Jun 15;21(12):2237-46. doi: 10.1200/JCO.2003.10.038. Epub 2003 May 14. J Clin Oncol. 2003. PMID: 12748244 Clinical Trial.
A phase II study of topotecan in patients with relapsed small-cell lung cancer.
Takeda K, Negoro S, Sawa T, Nakagawa K, Kawahara M, Isobe T, Kudoh S, Masuda N, Niitani H, Fukuoka M. Takeda K, et al. Among authors: nakagawa k. Clin Lung Cancer. 2003 Jan;4(4):224-8. doi: 10.3816/clc.2003.n.002. Clin Lung Cancer. 2003. PMID: 14624710
Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.
Ali Eldib AM, Ono T, Shimono M, Kaneko M, Nakagawa K, Tanaka R, Noguchi Y, Nakayama E. Ali Eldib AM, et al. Among authors: nakagawa k. Int J Cancer. 2004 Feb 10;108(4):558-63. doi: 10.1002/ijc.11587. Int J Cancer. 2004. PMID: 14696120
[Gefitinib in non-small cell lung cancer].
Nakagawa K. Nakagawa K. Nihon Rinsho. 2004 Jul;62(7):1312-20. Nihon Rinsho. 2004. PMID: 15283149 Review. Japanese. No abstract available.
Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer.
Kaneda H, Tamura K, Kurata T, Uejima H, Nakagawa K, Fukuoka M. Kaneda H, et al. Among authors: nakagawa k. Lung Cancer. 2004 Nov;46(2):247-54. doi: 10.1016/j.lungcan.2004.04.032. Lung Cancer. 2004. PMID: 15474673
3,945 results
Jump to page
Feedback